Cystinosis: From gene to disease

Nephrology Dialysis Transplantation

Volumn 17, Issue 11, 2002, Pages 1883-1886

  Kalatzis, Vasiliki ^a,c   Antignac, Corinne ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c INSTITUT DE GÉNÉTIQUE MOLÉCULAIRE DE MONTPELLIER   (France)

Author keywords

Cystine; Cystinosis; Fanconi syndrome; Lysosome; Transporter

Indexed keywords

CYSTEINE; CYSTINOSIN; MEMBRANE PROTEIN; MERCAPTAMINE; UNCLASSIFIED DRUG; CARRIER PROTEIN; CTNS PROTEIN, HUMAN; CYSTINE; GLYCOPROTEIN;

ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYSTINOSIS; DISEASE COURSE; DISEASE SEVERITY; FANCONI RENOTUBULAR SYNDROME; GENE MUTATION; HUMAN; KIDNEY FAILURE; LYSOSOME MEMBRANE; MOLECULAR CLONING; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; GENETICS; METABOLISM; MUTATION; REVIEW;

CYSTINE; CYSTINOSIS; GLYCOPROTEINS; HUMANS; MEMBRANE PROTEINS; MEMBRANE TRANSPORT PROTEINS; MUTATION;

EID: 0036842145     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/17.11.1883     Document Type: Article

References (23)

1. Gahl WA, Schneider JA, Aula PP. Lysosomal transport disorders: cystinosis and sialic acid storage disorders. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Basis of Inherited Disease. McGraw-Hill, New York, 1995; 3763-3797
2. Schneider JA, Bradley K, Seegmiller JE. Increased cystine in leukocytes from individuals homozygous and heterozygous for cystinosis. Science 1967; 157: 1321-1322
3. Schneider JA, Bradley K, Seegmiller JE. Increased free-cystine content of fibroblasts cultured from patients with cystinosis. Biochem Biophys Res Commun 1967; 29: 527-529
4. Steinherz R, Tietze F, Gahl WA et al. Cystine accumulation and clearance by normal and cystinotic leukocytes exposed to cystine dimethyl ester. Proc Natl Acad Sci USA 1982; 79: 4446-4450
5. Gahl WA, Bashan N, Tietze F, Bernardini I, Schulman JD. Cystine transport is defective in isolated leukocyte lysosomes from patients with cystinosis. Science 1982; 217: 1263-1265
6. Gahl WA, Tietze F, Bashan N, Bernardini I, Raiford D, Schulman JD. Characteristics of cystine counter-transport in normal and cystinotic lysosome-rich leucocyte granular fractions. Biochem J 1983; 216: 393-400
7. Town M, Jean G, Cherqui S et al. A novel gene encoding an integral membrane protein is mutated in nephropathic cystinosis. Nat Genet 1998; 18: 319-324
8. Forestier L, Jean G, Attard M et al. Molecular characterization of CTNS deletions in nephropathic cystinosis: development of a PCR-based detection assay. Am J Hum Genet 1999; 65: 353-359
9. Anikster Y, Lucero C, Touchman JW et al. Identification and detection of the common 65-kb deletion breakpoint in the nephropathic cystinosis gene (CTNS). Mol Genet Metab 1999; 66: 111-146
10. Thoene J, Lemons R, Anikster Y et al. Mutations of CTNS causing intermediate cystinosis. Mol Genet Metab 1999; 67: 283-293
11. Anikster Y, Lucero C, Guo J et al. Ocular nonnephropathic cystinosis: clinical, biochemical, and molecular correlations. Pediatr Res 2000; 47: 17-23
12. Attard M, Jean G, Forestier L et al. Severity of phenotype in cystinosis varies with mutations in the CTNS gene: predicted effect on the model of cystinosin. Hum Mol Genet 1999; 8: 2507-2514
13. Phornphutkul C, Anikster Y, Huizing M et al. The promoter of a lysosomal membrane transporter gene, CTNS, binds Sp-1, shares sequences with the promoter of an adjacent gene, CARKL, and causes cystinosis if mutated in a critical region. Am J Hum Genet 2001; 69: 712-721
14. Bois E, Feingold J, Frenay P, Briard M-L. Infantile cystinosis in France: genetics, incidence, geographic distribution. J Med Genet 1976; 13: 434-438
15. Kalatzis V, Cherqui S, Jean G et al. Characterization of a putative founder mutation that accounts for the high incidence of cystinosis in Brittany. J Am Soc Nephrol 2001; 12: 2170-2174
16. McDowell G, Isogai T, Tanigami A et al. Fine mapping of the cystinosis gene using an integrated genetic and physical map of a region within human chromosome band 17p13. Biochem Mol Med 1996; 58: 135-141
17. Shotelersuk V, Larson D, Anikster Y et al. CTNS mutations in an American-based population of cystinosis patients. Am J Hum Genet 1998; 63: 1352-1362
18. Cherqui S, Kalatzis V, Trugnan G, Antignac C. The targeting of cystinosin to the lysosomal membrane requires a tyrosine-based signal and a novel sorting motif. J Biol Chem 2001; 276: 13314-13321
19. Hunziker W, Geuze HJ. Intracellular trafficking of lysosomal membrane proteins. Bioessays 1996; 18: 379-389
20. Mancini GM, Havelaar AC, Verheijen FW. Lysosomal transport disorders. J Inherit Metah Dis 2000; 23: 278-292
21. Kalatzis V, Cherqui S, Antignac C, Gasnier B. Cystinosin, the protein defective in cystinosis, is a H(+)-driven lysosomal cystine transporter. EMBO J 2001; 20: 5940-5949
22. Greene AA, Clark KF, Smith ML, Schneider JA. Cystine exodus from normal leucocytes is stimulated by MgATP. Biochem J 1987; 246: 547-549
23. Coor C, Salmon RF, Quigley R, Marver D, Baum M. Role of adenosine triphosphate (ATP) and NaK-ATPase in the inhibition of proximal transport with intracellular cystine loading. J Clin Invest 1991; 87: 955-961